North America Embolization Coils Market

The North America embolization coils market is expected to grow from US$ 506.49 million in 2022 to US$ 661.63 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Increase in Incidence of Cancer Cases is Boosting the North America Embolization Coils Market

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cases of cancer expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing coils include detachable coils and pushable coils, which are used to fill or close blood vessels. The pushable coils are mechanical embolic agents used both in arteries and veins for various indications such as controlling bleeding, occluding vascular lesions such as aneurysms, varices, and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used to treat large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolization coils. This is bolstering the growth of the North America embolization coils market.

North America Embolization Coils Market Overview

North America region includes countries such as the US, Canada, and Mexico. All the three countries in the region are witnessing a sequential change in the embolization coils market. North America has the largest market share of the embolization coils market, by region. The market in the region is expected to grow significantly due to the rise in the number of FDA approvals to companies manufacturing embolization coils. In the US, the embolization coils market is anticipated to grow significantly owing to the rising number of brain aneurysms.

North America embolization coils Market Revenue and Forecast to 2028 (US$ Million)

North America Embolization Coils Strategic Insights

Strategic insights for the North America Embolization Coils provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Embolization Coils Report Scope

North America Embolization Coils Regional Insights

The geographic scope of the North America Embolization Coils refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America embolization coils market Segmentation

The North America embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the North America embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the North America embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the North America embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the North America embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.

Based on country, the North America embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.   

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the North America embolization coils market.